Skip to content

Exercise Prehabilitation in Congenital Heart Disease

A Randomised-controlled Trial to Assess the Impact of Prehabilitation and a Structured Exercise Programme on Cardiorespiratory Performance in Adults Awaiting Elective Surgery for Congenital Heart Disease: The ACE-CHD Trial.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07700459
Acronym
ACE-CHD
Enrollment
32
Registered
2026-07-14
Start date
2026-08-10
Completion date
2029-06-01
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Congenital Heart Disease

Keywords

Congenital heart disease, Prehabilitation, Cardiac surgery

Brief summary

Around 8-12 in every 1000 babies are born with an abnormal heart, known as a congenital heart defect (CHD). Thanks to major advances in medical and surgical care, most babies born with CHD now live into adulthood. As people with CHD get older, many need repeated heart operations. We now know from other areas of medicine that "prehabilitation" - a short, structured exercise programme completed before surgery - can improve fitness and help patients cope better with major operations. However, this approach has never been tested in adults with CHD. We are running a randomised controlled trial to find out whether a prehabilitation programme can improve physical fitness before heart surgery in adults with CHD. Participants will be randomly assigned to usual care or a prehabilitation group. Those in the prehabilitation group will follow a tailored, supervised exercise plan for several weeks before surgery. All patients undergoing cardiac surgery routinely complete a cardiopulmonary exercise test (CPET) as part of their standard pre-operative assessment. CPET is a well-established test that shows how the heart and lungs respond to increasing levels of exercise. During the test, participants exercise on a bike while their breathing, heart rate, and overall physiological response are continuously monitored. The results of each participant's routine CPET will be used to guide the individualised exercise programme in the intervention group. Exercise levels prescribed in the study will not exceed the intensity already safely achieved during the routine CPET, ensuring that activity remains within clinically assessed limits. Participants in the trial will complete an additional second CPET following the trial period. Our key question is whether a tailored exercise programme can improve fitness in adults with CHD before heart surgery, and whether this approach is feasible, acceptable and practical to deliver, including successful recruitment and measurable physiological improvements.

Interventions

Participants undertake a bespoke 6-week prehabilitation programme designed with an exercise physiologist, individualised to CPET results, baseline activity, and patient capability. It includes aerobic (progressive RPE-based, targeting 150-300 min/week moderate intensity with warm-up/cool-down), respiratory (inspiratory muscle training), and resistance training (major muscle groups, 15-30 repetitions, plus handgrip exercises). Equipment is provided. Participants also receive dietary and lifestyle advice with ongoing clinical support. Anxiety is addressed by the research team, with referral to psychology if required. Adherence is supported with at least fortnightly contact (phone/email/text). All participants undergo repeat CPET at 7-9 weeks. Participants are encouraged to continue exercises until surgery where feasible.

Sponsors

Liverpool Heart and Chest Hospital NHS Foundation Trust
Lead SponsorOTHER
Liverpool John Moores University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

The study will be outcome-blinded. Only the study team will have access to randomised allocation.

Intervention model description

This single-centre, prospective, outcome-blinded, feasibility, randomised controlled trial with a qualitative substudy, assessing prehabilitation in ACHD patients, excluding patients with high initial fitness levels, and hence less chance of clinical benefit from exercise prehabilitation impact, referred for elective cardiac surgery, will be conducted at Liverpool Heart and Chest Hospital (LHCH).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults with congenital heart disease requiring cardiac surgery via sternotomy or thoracotomy. * Capacity to provide informed consent. * Ability and willingness to engage in exercise-based interventions. * Peak VO2 \<30ml/kg/min at preoperative exercise assessment. * Participant reached peak VO2 in preoperative exercise assessment (RER \>1.0). * Ability to communicate in English.

Exclusion criteria

* Surgery is scheduled for a date that precludes participation in the programme - surgical date is \<9 weeks away. * Pregnancy of \<6 months postpartum. * History of pneumothorax within the last 3 months. * Resting oxygen saturations \<94%. * Uncorrected right-to-left shunt with exercise. * Fontan physiology. * Pulmonary hypertension. * Critical valvular obstruction. * Sustained ventricular arrhythmia. * Severe aortic dilatation (\>45mm in Marfan syndrome or hereditary aortopathy, \>50mm in bicuspid or tricuspid aortic valves). The oldest person operated upon by the ACHD service was 78 years old. Upper age is not an

Design outcomes

Primary

MeasureTime frameDescription
Within-participant change in peak VO2 as measured on cardiopulmonary exercise test (CPET) at baseline and follow-up.Baseline and follow-up CPETs (up to 9 weeks apart).The primary outcome will be the within-participant change in peak VO2 as measured on cardiopulmonary exercise test (CPET) at baseline and at follow-up.

Secondary

MeasureTime frameDescription
Individaul change in forced vital capacity (litres) at baseline and follow-up.Baseline and follow-up CPETs (up to 9 weeks apart)Best of three acceptable attempts after usual inhaled medications (if taken) at baseline and follow-up. This is a routine measurement on a CPET at LHCH.

Contacts

CONTACTElen H Hughes, MBBCh
elen.hughes@lhch.nhs.uk+44 01516001616
CONTACTJulia D Jones, MD
julia.jones3@lhch.nhs.uk+44 01516001616
PRINCIPAL_INVESTIGATORJulia D Jones, MD

Liverpool Heart and Chest Hospital NHS Foundation Trust

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026